维普期刊资源整合服务平台（V6.5）

350篇 您的检索式：作者名="ATTAL M"

选中清除导出查看参考文献查看引证文献引用追踪共18页首页上一页第1页下一页末页 /18 跳转

	题名	作者	年代	出处	被引量
1	EFNS的神经病理性痛药物治疗指南:2010修订显示文摘背景和目的欧洲神经病学协会联盟第2届工作组的目的是对2005年以来的关于神经病理性痛的药物治疗证据进行更新。方法使用Cochrane数据库和Medline选择相关研究,并根据病因学对研究分类。所有Ⅰ类和Ⅱ类随机对照研究(RCTs)均入选,低级别研究仅在没有高级别研究的情况下入选。考虑到对门诊患者治疗的可行性,只选择单药治疗或重复给药的研究。结果多数大型RCT的研究对象是糖尿病性多发性神经病和疱疹后神经痛的患者,越来越多的小型研究则对其他病因导致的神经病理性痛的治疗进行了探索。总体而言,药物治疗在除三叉神经痛、慢性神经根病和人类免疫缺陷病毒(HIV)神经病以外的各种病因中疗效相当,A级证据支持下列药物用于治疗神经病理性痛:三环类抗抑郁剂(TCA)、普瑞巴林、加巴喷丁、曲马多和阿片类(在不同情况下)、度洛西汀、文拉法辛、局部利多卡因和辣椒素贴剂(在限定的情况下)。联合用药有效仅见于TCA与加巴喷丁、加巴喷丁与阿片类(A级证据)。结论目前仍然缺乏大型的对比研究。我们建议今后的研究使用标准化工具对共病情况、生活质量、临床症状和体征进行评估,并致力于更好地确定对特定药物治疗的反应情况。	李建萍李颖林智李焰生 Attal N Cruccua G Barona R Haanpa M Hanssona P Jensena S Nurmikk T	2012	神经病学与神经康复学杂志2012，9，1：	14
2	Bortezomib(Velcade)plus decamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:preliminary results of an IFM phase II study显示文摘	Harousseau JL Attal M Leleu X	2004	Blood2004，104，：	1
3	Lenalidomide main- tenance after stern-cell transplantation for multiple myeloma 显示文摘	Attal M Lauwers-Cances V Marit G	2012	N Engl J Med2012，366，19：	1
4	Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma:results of the IFM 2005-01 phase Ⅲ trial显示文摘	Harousseau JL Attal M Avet-Loiseau H		0，，：	1
5	A pmspective,randomized trial of autologous bone marrwo transplantation and chemotherapy in multiple myeloma显示文摘	Attal M Harousseau JL Stoppa AM	1996	N Enggl J Med1996，335，：	1
6	Intramedul!ary nailing of the distal tibia illustrated with the Expert(TM) tibia nail显示文摘	El Attal R Hansen M Rosenberger R	2011	Oper Orthop Traumato12011，23，5：	1
7	Prevalence of chro- nic pain with neur0pathic characteristics in the general population 显示文摘	Bouhassira D Lanteri-Minet M Attal N	2008	Pain2008，136，：	1
8	High response rates to pomalidomide and dexamethasone in patients with refractory myeloma,final analysis of IFM 2009-02显示文摘	Leleu X Attal M Arnulf B		0，，：	1
9	Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome 显示文摘	Avet-Loiseau H Attal M Moreau P	2007	Blood2007，109，：	1
10	Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma显示文摘	Garban F Attal M Michallet M	2006	Blood2006，107，9：	1
11	The role of complete response in multiple myeloma显示文摘	Harousseau JL Attal M Avet-Loiseau H		0，，：	1
12	Genetic abnormalities and survival in multiple myeloma:the experience of the Intergroupe Franco- phone du Myelome 显示文摘	Avet-Loiseau H Attal M Moreau P	2007	Blood2007，109，8：	1
13	A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma显示文摘	Attal M Harousseau JL Stoppa AM	1996	N Engl J Ned1996，335，：	1
14	Maintenance therapy with thalidomide improves survival in patients with multiple myeloma显示文摘	Attal M Harousseau JL Leyvraz S	2006	Blood2006，108，10：	1
15	Single versus double autologous stem-cell transplantation for multiple myeloma 显示文摘	Attal M Harousseau JL Facon T	2003	N Engl J Med2003，349，：	1
16	Maintenance treatment with lenalido- mide after transplantation for MYELOMA:final analysis of the IFM 2005-02显示文摘	Attal M Lauwers VC Marit G	2010	Blood2010，116，21：	1
17	Thalidomide in patients with advanced multiple myeloma: a study of 83 palients - report of the intergroupe Francophone dn Myeloma(IFM) 显示文摘	Yakoub - Agha I Attal M Dumontet C	2002	Hematol J2002，3，4：	1
18	Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:results of an IFM phaseⅡstudy显示文摘	Harousseau JL Attal M Leleu X	2006	Haematologica2006，91，11：	1
19	Comparison of 200mg/m^2 melohaant and 8Gy total body irradiation plus 140mg/m^2 melphlan as conditioning regiments for petipheral blood stemcell transplantation in patients with newly diagnosis multiple myeloma:final analysis of the intergroup Francophone du Myeloma 9502 randomized trial显示文摘	Moreau P Facon T Attal M	2002	Blood2002，99，3：	1
20	Prospective comparison of autologous stem eell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma 显示文摘	Garban F Attal M Miehallet M	2006	Blood2006，107，：	1

返回顶部每页显示：

共18页首页上一页第1页下一页末页 /18 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示